 Navidea Biopharmaceuticals, Inc. NYSEMKT:NAVB Q2 2020 Results Earnings Conference Call August 13, 2020, 5:00 pm ET Company Participants Jed Latkin - Chief Executive Officer, Chief Financial Officer and Chief Operating Officer Mike Rosol - Chief Medical Officer Erika Gibson - Director of Finance and Administration Conference Call Participants Michael Okunewitch - Maxim Group Vernon Bernardino - H.C. 